Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun 28;19(6):e0306264.
doi: 10.1371/journal.pone.0306264. eCollection 2024.

Association between awareness and knowledge of medication-overuse headache with medication-taking behavior among adults with migraine

Affiliations

Association between awareness and knowledge of medication-overuse headache with medication-taking behavior among adults with migraine

Stacy C Bailey et al. PLoS One. .

Abstract

Frequent use of pain relief medications among patients with migraine can result in disease worsening and medication-overuse headache (MOH), a painful and debilitating condition. We sought to conduct a cross-sectional survey among adult patients diagnosed with migraine to determine: 1) their awareness of MOH, and 2) their knowledge of the condition and its prevention, and 3) the association of these factors with actual use of pain relief medications. We recruited and interviewed 200 English-speaking adults with migraine who had a clinic visit with a neurologist or primary care provider within the past month. Patients were identified via an electronic health record query. Almost 40% of participants had never heard of the term 'medication-overuse headache.' In bivariate analyses, participants who were Black or Hispanic and those with limited health literacy were less likely to have heard of MOH. Participants scored an average of 2.1 (range: 0-3) on a MOH knowledge measure; older participants, those with limited health literacy, lower education, and little or no migraine-related disability demonstrated less knowledge. Almost a third (31.5%) of patients reported overusing pain relief medication and were at risk for MOH. Overuse was not significantly associated with MOH awareness, knowledge, or sociodemographic factors, but was related to greater migraine-related disability. Our findings suggest that patient awareness and knowledge of MOH is suboptimal, particularly among older adults, racial and ethnic minority groups, and those with limited health literacy. Interventions are needed to prevent MOH and better inform patients about risks associated with frequent use of pain relief medications.

PubMed Disclaimer

Conflict of interest statement

SCB reports grants from Merck, Pfizer, Gordon and Betty Moore Foundation, RRF Foundation for Aging, Lundbeck, Gilead and Eli Lilly through her institution; and personal fees from Gilead, Sanofi, Pfizer, University of Westminster, Lundbeck, and Luto outside the submitted work. APP reports grants from Merck, Pfizer, Gordon and Betty Moore Foundation, RRF Foundation for Aging, Lundbeck, Gilead, and Eli Lilly through her institution; and personal fees from Gilead. MPH and DF are employees of H. Lundbeck A/S and Lundbeck LLC, respectively. SMK was an employee of Lundbeck LLC at the time when this manuscript was written. All other study authors have no conflicts of interest to report.

Similar articles

Cited by

References

    1. Buse DC, Greisman JD, Baigi K, Lipton RB. Migraine progression: A systematic review. Headache. 2019;59(3):306–338. doi: 10.1111/head.13459 - DOI - PubMed
    1. Lantéri-Minet M, Duru G, Mudge M, Cottrell S. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia. 2011;31(7):837–50. doi: 10.1177/0333102411398400 - DOI - PubMed
    1. Schwedt TJ, Hentz JG, Sahai-Srivastava S, et al.. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial. Headache. 2021;61(2):351–362. doi: 10.1111/head.14056 - DOI - PubMed
    1. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. doi: 10.1177/0333102413485658 - DOI - PubMed
    1. Abrams BM. Medication overuse headaches. Med Clin North Am. 2013;97(2):337–52. doi: 10.1016/j.mcna.2012.12.007 - DOI - PubMed